These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1971867)

  • 1. Soluble CD4: another therapeutic option in HIV infection.
    Lancet; 1990 May; 335(8698):1128-30. PubMed ID: 1971867
    [No Abstract]   [Full Text] [Related]  

  • 2. An anti-idiotype vaccine for AIDS based on the HIV receptor.
    Dalgleish AG
    Ann Ist Super Sanita; 1991; 27(1):27-31. PubMed ID: 1683525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Receptor of cells with infection of AIDS virus].
    Xu TG
    Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):29-33. PubMed ID: 1829542
    [No Abstract]   [Full Text] [Related]  

  • 4. [Binding of HIV-1 by "soluble" CD4 receptor--new therapeutic possibilities in AIDS].
    Nowak J
    Pol Tyg Lek; 1989 Apr; 44(17):401-2. PubMed ID: 2533976
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS and immune dysfunction. Alternative etiologic mechanisms.
    del Guercio P
    Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
    Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
    J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction between HIV and CD4 antigen and application of CD4 derivatives to AIDS therapy].
    Mizukami T
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(3):225-35. PubMed ID: 1691857
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4.
    Corre JP; Février M; Chamaret S; Thèze J; Zouali M
    Eur J Immunol; 1991 Mar; 21(3):743-51. PubMed ID: 1672646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS.
    Morgan RA; Looney DJ; Muenchau DD; Wong-Staal F; Gallo RC; Anderson WF
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):183-91. PubMed ID: 2328156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of soluble CD4 therapy by antibodies to HIV.
    Dis Markers; 1990; 8(2):107-8. PubMed ID: 2387123
    [No Abstract]   [Full Text] [Related]  

  • 11. The CD4-gp120 interaction and AIDS pathogenesis.
    Capon DJ; Ward RH
    Annu Rev Immunol; 1991; 9():649-78. PubMed ID: 1910691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
    Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
    J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological properties of a CD4 immunoadhesin.
    Byrn RA; Mordenti J; Lucas C; Smith D; Marsters SA; Johnson JS; Cossum P; Chamow SM; Wurm FM; Gregory T; Groopman JE; Capon DJ
    Nature; 1990 Apr; 344(6267):667-70. PubMed ID: 1970124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization.
    Healey DG; Dianda L; Buck D; Schroeder K; Truneh A; Sattentau QJ; Beverley PC
    Eur J Immunol; 1991 Jun; 21(6):1491-8. PubMed ID: 1710569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.
    Dimitrov DS; Norwood D; Stantchev TS; Feng Y; Xiao X; Broder CC
    Virology; 1999 Jun; 259(1):1-6. PubMed ID: 10364484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
    Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
    J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of HIV infection: perspectives].
    Monsuez JJ
    Pathol Biol (Paris); 1992 Jun; 40(6):609-20. PubMed ID: 1383913
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
    Mori T; Boyd MR
    Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients.
    Chams V; Idziorek T; Klatzmann D
    AIDS; 1991 May; 5(5):565-9. PubMed ID: 1677809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Janusin: new molecular design for bispecific reagents.
    Traunecker A; Lanzavecchia A; Karjalainen K
    Int J Cancer Suppl; 1992; 7():51-2. PubMed ID: 1428404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.